Crossmark

Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments

Crossref DOI link: https://doi.org/10.1016/j.reumae.2025.101806

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rubiño Juárez, Francisco

García de Vicuña, Rosario

Vicente, Esther

Rodríguez Almaraz, Esther

Lozano Rivas, Nuria

Freire González, Mercedes

Olivé Marqués, Alejandro

Nack, Annika

Narváez García, Javier

Moya Alvarado, Patricia

Uriarte Itzazelaia, Esther

Alcorta Lorenzo, Nerea

Marenco de la Fuente, José Luis

Ramos, Consuelo

Pinillos Aransay, Valvanera

Blanco Alonso, Ricardo

Benavides Villanueva, Fabricio

Martínez Vidal, María Paz

González Martín, Jesús María

Rúa-Figueroa, Íñigo
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01
More Information

This article is maintained by: Elsevier

Article Title: Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2025.101806

Content Type: article

Copyright: © 2024 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below